Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.

Saved in:
Bibliographic Details
Title: Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.
Authors: Raimondi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Tinè G; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Boige V; Department of Oncologic Medicine, Gustave-Roussy, Villejuif Cedex, France., De Stefano A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy., Ballhausen A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gourgou S; Biometrics Unit, Cancer Institute of Montpellier, Montpellier, France., Giuliani F; Medical Oncology IRCCS Giovanni Paolo II Bari and Medical Oncology San Paolo Hospital ASL, Bari, Italy., Stahler A; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Randon G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Manca P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Ambrosini M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Fazio R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Mohamed S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Gronchi G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Santabarbara G; Oncology Unit, San Giuseppe Moscati Hospital, Avellino, Italy., Brument E; UCGI, Prodige Intergroup, UNICANCER, Paris, France., Alig AHS; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Miceli R; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Bouche O; Department of Digestive Oncology, CHU Reims, Reims, France., Modest DP; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Avallone A; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Napoli, Italy., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.
Source: ESMO open [ESMO Open] 2026 Jul; Vol. 11 (7), pp. 107775. Date of Electronic Publication: 2026 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-7029
DOI:10.1016/j.esmoop.2026.107775